Alumis Inc. Common Stock (ALMS) has 18 tenedores institucionales e internos conocidos registrados. El mayor tenedor es AyurMaya Capital Management Company, LP con 15,139,707 acciones. Otros tenedores destacados incluyen Tananbaum James B. y Foresite Labs, LLC.
En los últimos 12 meses, los internos han realizado 66 transacciones en ALMS acciones — 60 compras (valoradas en $96.96M) y 0 ventas (valoradas en RSU Award). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.
ALMS Participación de Insiders
Principal Titular
AyurMaya Capital Management Company, LP
15,139,707 acciones
Compras (12 meses)
60
$96.96M valor
Ventas (12 meses)
0
$0.00 valor
Actividad de Transacciones (12 meses)
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Ayurmaya Capital Management Company, Lp |
10 Percent Owner, Other: See Remarks |
15,139,707 |
2025-05-23 |
|
| 2 |
Tananbaum James B. |
10 Percent Owner |
2,908,332 |
2026-01-12 |
|
| 3 |
Foresite Labs, Llc |
10 Percent Owner |
2,908,332 |
2026-01-12 |
|
| 4 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
2,908,332 |
2026-01-12 |
|
| 5 |
Akkaraju Srinivas |
Director |
1,853,488 |
2026-01-13 |
|
| 6 |
Babler Martin |
President, CEO and Chairman |
745,875 |
2026-01-28 |
|
| 7 |
Drappa Jorn |
Chief Medical Officer |
221,450 |
2026-01-28 |
|
| 8 |
Schroer John R. |
Chief Financial Officer |
202,225 |
2026-01-28 |
|
| 9 |
Hardiman Roy C. |
Chief Business & Strategy Ofcr |
190,875 |
2026-01-28 |
|
| 10 |
Bradley Mark Christopher |
Chief Development Officer |
190,225 |
2026-01-28 |
|
| 11 |
Pangali Sanam |
Chief Legal Officer |
186,200 |
2026-01-28 |
|
| 12 |
Yao Zhengbin |
Director |
49,800 |
2025-08-01 |
|
| 13 |
Srivastava Sapna |
Director |
49,800 |
2025-08-01 |
|
| 14 |
Tetrault Lynn A. |
Director |
49,800 |
2025-08-01 |
|
| 15 |
Machado Patrick |
Director |
49,800 |
2025-08-01 |
|
| 16 |
Richardson Derrick |
SVP, People and Culture |
42,800 |
2025-07-31 |
|
| 17 |
Colowick Alan |
Director |
16,104 |
2025-04-03 |
|
| 18 |
Goldstein David M |
Chief Scientific Officer |
8,994 |
2026-02-11 |
|
Transacciones Recientes (últimos 12 meses)
| Fecha |
Nombre |
Cargo |
Tipo |
Acciones |
Precio |
Valor |
| 2026-04-01 |
Foresite Labs, Llc |
10 Percent Owner |
Otro (Venta) |
1,123,337 |
- |
- |
| 2026-04-01 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Otro (Venta) |
1,123,337 |
- |
- |
| 2026-04-01 |
Tananbaum James B. |
10 Percent Owner |
Otro (Venta) |
1,123,337 |
- |
- |
| 2025-12-31 |
Goldstein David M |
Chief Scientific Officer |
Desconocido |
- |
- |
- |
| 2026-01-26 |
Pangali Sanam |
Chief Legal Officer |
Concesión de RSU |
186,200 |
$26.31 |
$4.9M |
| 2026-01-26 |
Bradley Mark Christopher |
Chief Development Officer |
Concesión de RSU |
190,225 |
$26.31 |
$5M |
| 2026-01-26 |
Drappa Jorn |
Chief Medical Officer |
Concesión de RSU |
221,450 |
$26.31 |
$5.83M |
| 2026-01-26 |
Goldstein David M |
Chief Scientific Officer |
Concesión de RSU |
216,675 |
$26.31 |
$5.7M |
| 2026-01-26 |
Schroer John R. |
Chief Financial Officer |
Concesión de RSU |
202,225 |
$26.31 |
$5.32M |
| 2026-01-26 |
Hardiman Roy C. |
Chief Business & Strategy Ofcr |
Concesión de RSU |
190,875 |
$26.31 |
$5.02M |
| 2026-01-26 |
Babler Martin |
President, CEO and Chairman |
Concesión de RSU |
745,875 |
$26.31 |
$19.62M |
| 2026-01-09 |
Akkaraju Srinivas |
Director |
Compra Informativa |
588,235 |
$17.00 |
$10M |
| 2026-01-08 |
Foresite Labs, Llc |
10 Percent Owner |
Compra Informativa |
294,117 |
$17.00 |
$5M |
| 2026-01-08 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Compra Informativa |
294,117 |
$17.00 |
$5M |
| 2026-01-08 |
Tananbaum James B. |
10 Percent Owner |
Compra Informativa |
294,117 |
$17.00 |
$5M |
| 2025-12-05 |
Akkaraju Srinivas |
Director |
Compra Informativa |
64,969 |
$8.95 |
$581.47K |
| 2025-12-04 |
Akkaraju Srinivas |
Director |
Compra Informativa |
66,027 |
$8.18 |
$540.1K |
| 2025-12-03 |
Akkaraju Srinivas |
Director |
Compra Informativa |
100,000 |
$7.75 |
$775K |
| 2025-12-02 |
Akkaraju Srinivas |
Director |
Compra Informativa |
96,000 |
$7.55 |
$724.8K |
| 2025-12-01 |
Akkaraju Srinivas |
Director |
Compra Informativa |
86,350 |
$7.46 |
$644.17K |
| 2025-11-28 |
Akkaraju Srinivas |
Director |
Compra Informativa |
38,702 |
$7.64 |
$295.68K |
| 2025-11-26 |
Akkaraju Srinivas |
Director |
Compra Informativa |
48,537 |
$7.64 |
$370.82K |
| 2025-11-21 |
Foresite Labs, Llc |
10 Percent Owner |
Compra Informativa |
72,212 |
$7.38 |
$532.92K |
| 2025-11-21 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Compra Informativa |
72,212 |
$7.38 |
$532.92K |
| 2025-11-21 |
Tananbaum James B. |
10 Percent Owner |
Compra Informativa |
72,212 |
$7.38 |
$532.92K |
